A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY MICROMETHOD FOR THE SIMULTANEOUS DETERMINATION OF VIGABATRIN AND GABAPENTIN IN SERUM

Citation
N. Ratnaraj et Pn. Patsalos, A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY MICROMETHOD FOR THE SIMULTANEOUS DETERMINATION OF VIGABATRIN AND GABAPENTIN IN SERUM, Therapeutic drug monitoring, 20(4), 1998, pp. 430-434
Citations number
17
Categorie Soggetti
Pharmacology & Pharmacy","Public, Environmental & Occupation Heath",Toxicology,Biology
Journal title
ISSN journal
01634356
Volume
20
Issue
4
Year of publication
1998
Pages
430 - 434
Database
ISI
SICI code
0163-4356(1998)20:4<430:AHLMFT>2.0.ZU;2-A
Abstract
A gradient high-performance liquid chromatography micromethod is descr ibed for the simultaneous quantitation of vigabatrin and gabapentin in human serum. Chromatography was performed using a 125- x 3-mm ID Hype rsil BDS C-18 column with a 3-mu m mini-bore, eluted with a gradient s ystem comprised of phosphate buffer (pH 6.5)-acetonitrile-methanol-wat er at a flow rate of 0.45 ml/minute. The column eluent was monitored o n a fluorescence detector using excitation and emission wavelengths of 340 and 440 nm, respectively. The lower limit of quantitation for vig abatrin and for gabapentin was 5 mu mol/l, and the within batch and be tween-batch coefficients of variation were <5%. No interference from c ommonly prescribed antiepileptic drugs (carbamazepine and its metaboli te carbamazepine epoxide, oxcarbazepine and its metabolite 10-hydroxyi carbazepine, ethosuximide, lamotrigine, phenobarbitone, phenytoin, pri midone, and valproic acid) was observed; thus, the method can be used to monitor vigabatrin and gabapentin in patients on polytherapy antiep ileptic drug regimens.